Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma

NCT05062759 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Asthma

Interventions

DRUG: Tezepelumab
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]